HCV Patient Assistance Programs; Important Factors Worth
By: Marcus Hopkins, Blogger
One of our primary concerns, here at the HEAL Blog, is the affordability
of treatment for those mono- or co-infected with Hepatitis C. Arguably the
most highly discussed treatment option for HCV is Sovaldi, one of the newer
therapies offered by Gilead Sciences, largely because of the high price tag
associated with the drug. Coming in at an estimated $85k for a twelve-week
treatment regimen, the controversy over pharmaceutical pricing has been reignited
in a way not seen in over a decade.
CLICK HERE to read, HCV Patient Assitance Program
Black Market HIV/AIDS Drugs in the News, 2006 -
The Partnership for Safe Medicines
The Community Access National Network (CANN) today announced that it is teaming
up with the Partnership for Safe Medicines (PSM) to better educate patients
about the risks of counterfeit or black market HIV/AIDS medicines. Since
2006, eighty-two (82) individuals have been charged with selling adulterated,
unapproved or black market medications prescribed for HIV or AIDS patients.
HERE to download, "Black Market HIV/AIDS Drugs in the News, 2006 - 2013"